Clinical trial
Effects of N-Methyl-D-Aspartate (NMDA)-Receptor Antagonism on Hyperalgesia…
NCT00188383 · University Health Network, Toronto, Other · Unknown status
Key facts
| NCT number | NCT00188383 |
|---|---|
| Title | Effects of N-Methyl-D-Aspartate (NMDA)-Receptor Antagonism on Hyperalgesia, Opioid Use, and Pain After Radical Prostatectomy |
| Official title | Effects of NMDA-Receptor Antagonism on Hyperalgesia, Opioid Use, and Pain After Radical Prostatectomy in Young and Elderly Patients |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | Canadian Institutes of Health Research (CIHR) |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Hyperalgesia, Pain, Prostate Cancer |
| Intervention type | Drug |
| Interventions | Amantadine |
| Enrollment | 132 |
| Start date | Jan 1, 2004 |
| Completion | Dec 1, 2006 |
| First posted | Sep 16, 2005 |
| Last update posted | Mar 14, 2006 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: